If you have been exposed (bitten, scratched or licked) by an animal that might have rabies, you’ll need to seek medical advice to determine whether you need to have a course of treatment to prevent rabies.
This is called post-exposure treatment. It can usually prevent a rabies infection from becoming established and producing symptoms.
Post-exposure treatment involves three stages:
Immediately after being bitten, you should:
If you think your eye may have been infected with the saliva of an animal, wash it thoroughly with clean water and seek medical help.
If you’ve been in a high-risk situation, you may also be given an injection of rabies immunoglobulin as well as the rabies vaccination. This helps protect you against the virus while your body is developing antibodies after vaccination.
The immunoglobulin works by providing ready-made antibodies designed to neutralise the rabies virus and prevent it spreading. Apart from some temporary soreness at the injection site, rabies immunoglobulin doesn’t usually cause any side effects.
The rabies vaccine should be given in every case of suspected exposure to rabies. The length of your vaccination course will depend on whether you have previously been vaccinated.
You should receive five doses of the vaccine if you’ve never been vaccinated. The first dose is given at the beginning of the treatment, followed by four further doses, which are given three, seven, 14 and 30 days after the start of treatment.
If you’ve previously been vaccinated, you should receive two doses of the vaccine. The first dose is given at the start of your treatment, followed by a second dose three to seven days later. The doses are given by injection into the shoulder muscle.
A common side effect of the rabies vaccine is redness, swelling and pain at the injection site, which occurs 24 to 48 hours after the injection has been given.
Worldwide, there are three types of rabies vaccine:
The World Health Organization (WHO) only recommends purified cell culture or embryonated egg-based vaccines (CCEEVs), which include HDCV or PCEC, should be used. This is because there are safety concerns over the nerve tissue vaccine.
Researchers found this type of vaccine has a 1 in 650 chance of causing serious complications that can result in permanent disability, such as muscle paralysis. Despite this, it should be taken if it is the only vaccine available.
A small number of countries have not followed the WHO recommendations and may still use the nerve tissue vaccine. They include Ecuador, Peru, Myanmar (Burma) and Pakistan.
Once a person develops symptoms, the disease is usually fatal. Treatment involves keeping the person comfortable and treating complications.
To date, there have been no reported cases of human-to-human transmission of rabies. However, it’s theoretically possible, so anyone who has been in close contact with someone who has a rabies infection may be advised to have post-exposure treatment as a precaution.
SOURCE: NHS UK